Table 2.
Demographic and other baseline characteristics (n = 48)
| Parameter | Overall n = 48 |
Pharmacokinetic set 1a n = 32 |
Pharmacokinetic set 2b n = 32 |
|---|---|---|---|
| Sex | |||
| Female | 25 (52.1) | 15 (46.9) | 17 (53.1) |
| Male | 23 (47.9) | 17 (53.1) | 15 (46.9) |
| Age (years) | 51.1 ± 6.6 | 52.0 ± 6.4 | 51.5 ± 6.8 |
| Body weight (kg) | 69.19 ± 9.91 | 68.96 ± 8.84 | 70.58 ± 10.44 |
| Height (cm) | 168.3 ± 9.4 | 168.5 ± 8.8 | 168.8 ± 9.6 |
| BMI (kg/m2) | 24.37 ± 2.25 | 24.27 ± 2.26 | 24.69 ± 2.18 |
| Race | |||
| White | 47 (97.9) | 31 (96.9) | 32 (100) |
| Other | 1 (2.1) | 1 (3.1) | 0 |
Values are mean ± SD or n (%)
BMI body mass index, SD standard deviation, ODF orally disintegrating film
aAll subjects randomised to the vitamin D3 ODF (Testfed) and the vitamin D3 oral solution fed (Referencefed) groups and completed the study
bAll subjects randomised to the Testfed and the Testfast groups and completed the study